Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IMM-H007 是一种新型降脂剂,可增加 abca1 蛋白的表达。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 579 | 现货 | ||
2 mg | ¥ 866 | 现货 | ||
5 mg | ¥ 1,490 | 现货 | ||
10 mg | ¥ 2,320 | 现货 | ||
25 mg | ¥ 3,980 | 现货 | ||
50 mg | ¥ 5,630 | 现货 | ||
100 mg | ¥ 7,630 | 现货 | ||
500 mg | ¥ 15,200 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,690 | 现货 |
产品描述 | IMM-H007 is a novel lipid-lowering agent, increasing abca1 protein expression |
体外活性 | IMM-H007 (H007) significantly inhibits monocyte adhesion to endothelial cells and its transendothelial migration.?Mechanistically, H007 markedly represses TNFα-induced IκBα degradation and NF-κB nuclear translocation, therefore leading to NF-κB-mediated inflammatory suppression.?Moreover, another inflammatory signaling JNK/c-Jun, which is always co-activated with NF-κB in response to pro-inflammatory stimuli, is also found to be restrained by H007 through reducing its phosphorylation status.?H007 negatively regulates endothelium inflammation through inactivating NF-κB and JNK/AP1 signaling. |
分子量 | 485.45 |
分子式 | C22H23N5O8 |
CAS No. | 1221412-23-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (60.91 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.0599 mL | 10.2997 mL | 20.5994 mL | 51.4986 mL |
5 mM | 0.412 mL | 2.0599 mL | 4.1199 mL | 10.2997 mL | |
10 mM | 0.206 mL | 1.03 mL | 2.0599 mL | 5.1499 mL | |
20 mM | 0.103 mL | 0.515 mL | 1.03 mL | 2.5749 mL | |
50 mM | 0.0412 mL | 0.206 mL | 0.412 mL | 1.03 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
IMM-H007 1221412-23-2 Chromatin/Epigenetic Others PI3K/Akt/mTOR signaling AMPK JNK Nuclear factor-κB WS 070117 IMM H007 AP-1 inflammatory WS070117 inhibit atherosclerosis Transforming growth factor beta receptors Activator Protein 1 cardiac fibrosis IMM-H 007 JNK/c-Jun IMMH007 IMM-H-007 NF-κB Nonalcoholic fatty liver disease NAFLD WS-070117 TGF-β Receptor AMP-activated protein kinase Nuclear factor-kappaB Inhibitor inhibitor